[TankerOne]

About Biotech News Stock Review. BMSN. BMSN. BMSN. News and Events
Wednesday, 06 February 2013 00:00

Regen BioPharma announced today filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company's HemaXellerate I™ stem cell drug in patients with drug-refractory aplastic anemia. Cromos Pharma's team took active part in IND application preparation.
More details can be found at Regen Biopharma website and press-release. BMSN. BMSN. BMSN. News and messages from CEO,
Dr Vladimir Bogin
05.02.2013
Cromos™ Pharma helps Regen Biopharma in filing of an Investigational New Drug (IND) application with the FDA
[...]
BMSN. BMSN. BMSN. SATURDAY, FEBRUARY 16, 2013

Cut To The Chase_FDA WILL Approve Bio-Matrix Scientific (BMSN) IND Application, Share Price To Hit 10 Cents Prior To Clinical Trials Forecasts Sierra World Equity Review
HEADLINE: Cut To The Chase_FDA WILL Approve Bio-Matrix Scientific (BMSN) IND Application, Share Price To Hit 10 Cents Prior To Clinical Trials Forecasts Sierra World Equity Review BMSN Stock related, I was going to wait until Monday to release this but as my headline says, I'll cut to the chase! Bio-Matrix Scientific (BMSN) is not going to have any problems with their IND application, look for new press releases within 30 days giving information on the start of clinical trials. BMSN longs enjoy the ride all the way to the bank! BMSN. BMSN. BMSN.